PUBLISHER: GlobalData | PRODUCT CODE: 1410792
PUBLISHER: GlobalData | PRODUCT CODE: 1410792
Gastric Bands and Balloons Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Gastric Bands and Balloons market for the year 2020 and beyond. Gastric Bands and Balloons include surgical procedures used for the management of body weight in patients with severe obesity. It is one of the most effective long-term strategies and is recommended by country-specific guidelines for adult patients. Medical devices that are used to perform bariatric surgery are referred to as Gastric Bands and Balloons.
Gastric Bands and Balloons include gastric balloons, gastric bands and or adjustable gastric bands. A gastric balloon is an inflatable and expandable device that is implanted into the stomach. The procedure is a non-invasive and reversible procedure. Gastric bands or adjustable gastric bands are inflatable silicone devices that are surgically implanted into the upper portion of the stomach to reduce the size of the stomach's opening.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Gastric Bands and Balloons and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Allurion Technologies, Inc., ReShape Lifesciences Inc, Spatz FGIA, Inc, Cousin Surgery, Q Medical International AG, Districlass Medical SA, Laboratoire Endalis, EBOS Group Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable